Verdane Invests in Clue to Accelerate Future of Women’s Health

The investment - which is a substantial contribution from Verdane's €2 billion growth fund - is the single largest investment in Clue

Clue, a women-led period and cycle tracker health and wellness app, with over 100 million downloads worldwide, today announced a significant and strategic investment from Verdane - the European specialist growth equity firm focused on technology-enabled businesses.

The investment - which is a substantial contribution from Verdane's €2 billion growth fund - is the single largest investment in Clue to date and marks a noteworthy milestone for the business.

The funding, which will result in Verdane being the largest investor in the women’s health and wellness app, follows an exceptional 2025 that strengthened Clue’s growth foundations and created a clear path to long-term and sustainable profitability.

With Verdane’s partnership, Clue will accelerate its next phase of growth, including:

Deepening product innovation, user experience and feature development

Expanding global reach by scaling new and existing markets

Investing in healthcare partnerships to expand access to more personalised care

Investing in clinical and world-class research to inform our product excellence and continue to close the women’s health gap

Strengthening market-leading privacy-first and security measures

Investing in technology that aids in delivering more personalised care

A Shared Vision for a Critically Underserved Category

Clue and Verdane are united by a shared belief that women’s health remains one of the most underserved and most impactful categories in global health and wellness. Both organisations recognise the opportunity to build category-defining companies that combine scientific rigor, ethical data practices, and long-term thinking to deliver meaningful outcomes for users and society.

Clue has long differentiated itself through its commitment to medical research, and science-based insights, leading data privacy standards, and an inclusive approach to women’s health that goes beyond fertility tracking alone. Verdane brings deep experience partnering with mission-driven, digital-first companies, helping them scale responsibly while staying true to their values and ethical positioning.

Rhiannon White, CEO at Clue, said: ‘’Women are the world’s largest health and wellness consumers, controlling the majority of household spending in every market, yet they remain strikingly underserved relative to their economic power. This gap creates three systemic pain points: a profound lack of accessible female health knowledge that forces women to self-diagnose, a confusing marketplace filled with unproven products and little evidence-based guidance, and persistent barriers to accessing care. For businesses, this represents not just a social issue but a significant market failure and a compelling opportunity to build trusted, data-driven solutions that meet the needs of the most influential spenders in global health and wellness.

Partnering with Verdane enables us to accelerate the creation of this powerful ecosystem and tackle these issues for women. Verdane’s deep expertise in growing sustainable businesses, combined with their extensive operating experience in the health and wellness space, means they bring unparalleled support to the opportunity in front of us.”